Sign up to save your podcasts
Or
Share Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial
Host: Pavani Chalasani, MD, MPH
Guest: Hope S. Rugo, MD, FASCO
Results from the TROPiCS-02 trial may impact survival for patients with receptor–positive/HER2-negative breast cancer. To find out why, Dr. Hope Rugo from the University of California San Francisco Comprehensive Cancer Center joins Dr. Pavani Chalasani to talk about the study and how it might impact the future of breast cancer treatment.
View all episodes
Host: Pavani Chalasani, MD, MPH
Guest: Hope S. Rugo, MD, FASCO
Results from the TROPiCS-02 trial may impact survival for patients with receptor–positive/HER2-negative breast cancer. To find out why, Dr. Hope Rugo from the University of California San Francisco Comprehensive Cancer Center joins Dr. Pavani Chalasani to talk about the study and how it might impact the future of breast cancer treatment.